• Arshad Parvez
  • Ihsan ullah
  • Ahmad Rafiq
  • Nisar Ahmad
  • Ejaz Hassan Khan


Background: Diabetes mellitus (DM) is a metabolic disorder characterised by chronichyperglycaemia with disturbances in carbohydrate, fat and protein metabolism arising from defectin insulin secretion or action or both. The clinical guidelines recommend measurement of BMI as“vital signs” for evaluating the obese and diabetic patients. Methods: This study was carried outon 160 diabetics, which were divided on the basis of BMI into obese (120) and non-obese (40)diabetics from Peshawar district. All patients had their triglycerides and glucose checked afterover night fast. Results: The serum triglyceride in diabetics having BMI >30 (obese) wasincreased as compared to patients having BMI <30 (non-obese). The comparison of serum glucoselevel in obese diabetics was found to be significantly raised as compared to non-obese diabetics.Conclusions and Recommendations: It was concluded that dyslipidemia is common in alldiabetics. The abnormal triglyceride level can improve with good glycaemic control, but do notreach the normal state. Good glycaemic control, Reducing BMI, periodic checkups of lipids andblood glucose are recommended for all diabetics in order to avoid complications.Keywords: Triglyceride, BMI, obese, non-obese, type 2 diabetics


Marshall WJ. Lipids and lipoproteins. Clinical chemistry, 4th

Ed. London: Mosby book; 2000. p. 231–5.

Mayne, PD: Hyperglycemia and diabetes mellitus. In: Zilva’s

clinical chemistry in diagnosis and treatment. 6th Ed. Glasgow:

Bath Press Color Books: 1994.p 206–9.

Roldofo V. Detecting undiagnosed type 2 diabetes: family

history as a risk factor and screening tool. J Diabetes Sci

Technol 2009;3:722–6.

Dedoussis, GV, Kaliora AC, Panagiotakos DB. Genes diet and

type-2 diabetes: areview. Diabetes care 2007;4(1): 13–24.

Betterridge DJ. Diabetic dyslipidemia. Diabetes Care

;2(Suppl 1):31–6.

Malik MS, Raza SN, Hussain. Diabetic control and serum

lipids in diabetics attending a Pakistani Hospital. Pak J Med Sci


Chetlin RD, Brinkley JL, Spatafore AJ, Gilleland DL, Wheele

SD. Assessing Quality-of-life, Roles, And BMI in Type 2

Diabetes Patients Participating In Supervised Exercise. Med

Sci Sports Exerc 2009;41(5):440.

Oh Rc, Brain JL. Management of Hypertriglyceridemia. Am

Fam Physician 2007;75:1365–71.

Bray GA, Gray DS. Obesity, Part I, Pathogenesis. West J Med


J Ayub Med Coll Abbottabad 2010;22(2)

Jafar TH, Chaturvedi N, Pappas G. Prevalence of overweight

and obesity and their association with hypertension and

diabetes mellitus in an Indo-Asian population. CMAJ


Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL.

Overweight and obesity in the United States: prevalence and

trends, 1960–94. Int J Obes Relat Metab Disord


Bland M. Introduction to medical statistics 1st Ed. London:

(Reprinted) ELBS;1989.p.64–75.

Amer W, Zafar S, Majrooh A. Comparison of dyslipidemias in

controlled and uncontrolled type 2 diabetics. Ann King Edward

Med Coll 2004;10(2):158–60.

Garg A, Grundy SM. Gemfibrozil alone and in combination

with lovastatin for treatment of hypertriglyceridemia in

NIDDM. Diabetes 1989;38:364–72.

Arbeeny CM, Nordin C, Edelstein D, Stran N, Gibbons N,

Eder HA. Hyperlipoproteinimia in spontaneously diabetic

guinea pigs. Metabolism 1989;38:895–900.

Haider Z, Usma S, Jabeen M, Bano KA, Obaidullah S, Fayyaz

A. Profiles of hyperlipidemia in various patient groups and

controls. Pak J Med Res 1981;20(3):63–6.

Lampman RM, Schteingart DE. Effects of exercise training on

glucose control, lipid metabolism, and insulin sensitivity in

hypertriglyceridemia and non-insulin dependent diabetes

mellitus. Med Sci Sports Exerc 1991;23(6):703–12.